319 related articles for article (PubMed ID: 16775648)
1. Antimicrobials, mucosal coating agents, anesthetics, analgesics, and nutritional supplements for alimentary tract mucositis.
Barasch A; Elad S; Altman A; Damato K; Epstein J
Support Care Cancer; 2006 Jun; 14(6):528-32. PubMed ID: 16775648
[TBL] [Abstract][Full Text] [Related]
2. The role of alternative and natural agents, cryotherapy, and/or laser for management of alimentary mucositis.
Migliorati CA; Oberle-Edwards L; Schubert M
Support Care Cancer; 2006 Jun; 14(6):533-40. PubMed ID: 16572313
[TBL] [Abstract][Full Text] [Related]
3. Growth factors and cytokines in the prevention and treatment of oral and gastrointestinal mucositis.
von Bültzingslöwen I; Brennan MT; Spijkervet FK; Logan R; Stringer A; Raber-Durlacher JE; Keefe D
Support Care Cancer; 2006 Jun; 14(6):519-27. PubMed ID: 16775647
[TBL] [Abstract][Full Text] [Related]
4. Alimentary mucositis: putting the guidelines into practice.
Brennan MT; von Bültzingslöwen I; Schubert MM; Keefe D
Support Care Cancer; 2006 Jun; 14(6):573-9. PubMed ID: 16622650
[TBL] [Abstract][Full Text] [Related]
5. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Lalla RV; Bowen J; Barasch A; Elting L; Epstein J; Keefe DM; McGuire DB; Migliorati C; Nicolatou-Galitis O; Peterson DE; Raber-Durlacher JE; Sonis ST; Elad S;
Cancer; 2014 May; 120(10):1453-61. PubMed ID: 24615748
[TBL] [Abstract][Full Text] [Related]
6. Mucositis guidelines: what have they achieved, and where to from here?
Keefe DM
Support Care Cancer; 2006 Jun; 14(6):489-91. PubMed ID: 16572311
[No Abstract] [Full Text] [Related]
7. Developing evidence-based guidelines for management of alimentary mucositis: process and pitfalls.
Keefe DM; Peterson DE; Schubert MM
Support Care Cancer; 2006 Jun; 14(6):492-8. PubMed ID: 16601949
[TBL] [Abstract][Full Text] [Related]
8. Systematic review of antimicrobials, mucosal coating agents, anesthetics, and analgesics for the management of oral mucositis in cancer patients and clinical practice guidelines.
Saunders DP; Rouleau T; Cheng K; Yarom N; Kandwal A; Joy J; Bektas Kayhan K; van de Wetering M; Brito-Dellan N; Kataoka T; Chiang K; Ranna V; Vaddi A; Epstein J; Lalla RV; Bossi P; Elad S;
Support Care Cancer; 2020 May; 28(5):2473-2484. PubMed ID: 32052137
[TBL] [Abstract][Full Text] [Related]
9. Promulgation of guidelines for mucositis management: educating health care professionals and patients.
McGuire DB; Johnson J; Migliorati C
Support Care Cancer; 2006 Jun; 14(6):548-57. PubMed ID: 16775650
[TBL] [Abstract][Full Text] [Related]
10. Anti-inflammatory agents in the management of alimentary mucositis.
Lalla RV; Schubert MM; Bensadoun RJ; Keefe D
Support Care Cancer; 2006 Jun; 14(6):558-65. PubMed ID: 16565821
[TBL] [Abstract][Full Text] [Related]
11. Amifostine in the management of radiation-induced and chemo-induced mucositis.
Bensadoun RJ; Schubert MM; Lalla RV; Keefe D
Support Care Cancer; 2006 Jun; 14(6):566-72. PubMed ID: 16586122
[TBL] [Abstract][Full Text] [Related]
12. Alimentary tract mucositis in cancer patients: impact of terminology and assessment on research and clinical practice.
Peterson DE; Keefe DM; Hutchins RD; Schubert MM
Support Care Cancer; 2006 Jun; 14(6):499-504. PubMed ID: 16775646
[TBL] [Abstract][Full Text] [Related]
13. Development of the MASCC/ISOO Clinical Practice Guidelines for Mucositis: considerations underlying the process.
Elad S; Bowen J; Zadik Y; Lalla RV;
Support Care Cancer; 2013 Jan; 21(1):309-12. PubMed ID: 23064884
[TBL] [Abstract][Full Text] [Related]
14. Methodology for the MASCC/ISOO Mucositis Clinical Practice Guidelines Update.
Bowen JM; Elad S; Hutchins RD; Lalla RV;
Support Care Cancer; 2013 Jan; 21(1):303-8. PubMed ID: 22960942
[TBL] [Abstract][Full Text] [Related]
15. Advances in the understanding and management of mucositis during stem cell transplantation.
Bowen JM; Wardill HR
Curr Opin Support Palliat Care; 2017 Dec; 11(4):341-346. PubMed ID: 28984677
[TBL] [Abstract][Full Text] [Related]
16. Systematic review of anti-inflammatory agents for the management of oral mucositis in cancer patients and clinical practice guidelines.
Ariyawardana A; Cheng KKF; Kandwal A; Tilly V; Al-Azri AR; Galiti D; Chiang K; Vaddi A; Ranna V; Nicolatou-Galitis O; Lalla RV; Bossi P; Elad S;
Support Care Cancer; 2019 Oct; 27(10):3985-3995. PubMed ID: 31286230
[TBL] [Abstract][Full Text] [Related]
17. Development of the MASCC/ISOO clinical practice guidelines for mucositis: an overview of the methods.
Ranna V; Cheng KKF; Castillo DA; Porcello L; Vaddi A; Lalla RV; Bossi P; Elad S;
Support Care Cancer; 2019 Oct; 27(10):3933-3948. PubMed ID: 31286227
[TBL] [Abstract][Full Text] [Related]
18. MASCC/ISOO clinical practice guidelines for the management of mucositis secondary to cancer therapy.
Elad S; Cheng KKF; Lalla RV; Yarom N; Hong C; Logan RM; Bowen J; Gibson R; Saunders DP; Zadik Y; Ariyawardana A; Correa ME; Ranna V; Bossi P;
Cancer; 2020 Oct; 126(19):4423-4431. PubMed ID: 32786044
[TBL] [Abstract][Full Text] [Related]
19. The role of basic oral care and good clinical practice principles in the management of oral mucositis.
McGuire DB; Correa ME; Johnson J; Wienandts P
Support Care Cancer; 2006 Jun; 14(6):541-7. PubMed ID: 16775649
[TBL] [Abstract][Full Text] [Related]
20. Systematic review of agents for the management of gastrointestinal mucositis in cancer patients.
Gibson RJ; Keefe DM; Lalla RV; Bateman E; Blijlevens N; Fijlstra M; King EE; Stringer AM; van der Velden WJ; Yazbeck R; Elad S; Bowen JM;
Support Care Cancer; 2013 Jan; 21(1):313-26. PubMed ID: 23142924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
